PROCESSED AT :

HY PATHO LAB NAGPUR

PT Name : MR RADHESHYAM Age : 42 Year | Sex : Male SAMPLE COLLECTED AT :

Ref By : DR. V.K.SHYAMKUVAR Registered on : 28-06-2025 10:15 AM
Reg No : HL5900686435 / NAGPURLAB/NGP013 Received on : 28-06-2025 12:42 PM
Barcode : EC135375 Reported on : 28-06-2025 02:18 PM
INV : HY MONSOON-1 SAMPLE : Serum

VITAMIN B12

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGE

VITAMIN B-12 418.1 pg/ml 211 - 911

Method: CLIA

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,
such as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation
and in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA
synthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in
conjunction with the patients medical history, clinical examination and other findings.

Specifications: Intra assay (%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml

Please correlate with clinical conditions.

~~End of report~~

Dr. SUVARNA KALAMBE (MD PATH)

Consultant Pathologist (Reg. 418)

1 of 11
 PROCESSED AT :
HY PATHO LAB NAGPUR

PT Name : MR RADHESHYAM Age : 42 Year | Sex : Male SAMPLE COLLECTED AT :

Ref By : DR. V.K.SHYAMKUVAR Registered on : 28-06-2025 10:15 AM
Reg No : HL5900686435 / NAGPURLAB/NGP013 Received on : 28-06-2025 12:42 PM
Barcode : EC135375 Reported on : 28-06-2025 02:52 PM
INV : HY MONSOON-1 SAMPLE : Serum

25 OH VITAMIN D 3 TOTAL

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGE

25-OH VITAMIN D 3 (TOTAL) 17.25 ng/mL 30 - 100

Method: CLIA

Reference Range
Deficiency < 20 ng/mL
Insufficiency 20– 30 ng/mL
Sufficiency 30–100 ng/mL
Toxicity :>100 ng/mL

Vitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D Standardization Program (VDSP).

Specifications: Intra assay (%CV):5.3%, Inter assay (%CV):11.9% ; Sensitivity:3.2 ng/ml

Please correlate with clinical conditions.

Method : Fully Automated Chemi Luminescent Immuno Assay

~~End of report~~

Dr. SUVARNA KALAMBE (MD PATH)

Consultant Pathologist (Reg. 418)

2 of 11
 PROCESSED AT :
HY PATHO LAB NAGPUR

PT Name : MR RADHESHYAM Age : 42 Year | Sex : Male SAMPLE COLLECTED AT :

Ref By : DR. V.K.SHYAMKUVAR Registered on : 28-06-2025 10:15 AM
Reg No : HL5900686435 / NAGPURLAB/NGP013 Received on : 28-06-2025 12:42 PM
Barcode : HE417231 Reported on : 28-06-2025 01:50 PM
INV : HY MONSOON-1 SAMPLE : EDTA Blood

GLYCATED HAEMOGLOBIN (HBA1C)

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGE

HBA1C 5.7 % 0 - 6.5

Method: Fully Automated H.P.L.C.

BIOLOGICAL REFERENCE RANGES

Reference Range: As per ADA Guidelines Guidance For Known Diabetics

Below 6.5% : Good Control

Below 5.7% : Normal
6.5% - 7% : Fair Control
5.7% - 6.4% : Prediabetic
7.0% - 8% : Unsatisfactory Control
>=6.5% : Diabetic
>8% : Poor Control

Estimated Average Glucose : 116.89 mg/dl .-.

Method: CALCULATED

Reference Range
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control

Clinical significance :
Hemoglobin A1c (HbA1c) is a result of the nonenzymatic attachment of a hexose molecule to the N-terminal amino acid of the hemoglobin molecule. The
attachment of the hexose molecule occurs continually over the entire life span of the erythrocyte and is dependent on blood glucose concentration and the duration
of exposure of the erythrocyte to blood glucose. Therefore, the HbA1c level reflects the mean glucose concentration over the previous period (approximately 8-12
weeks, depending on the individual) and provides a much better indication of long-term glycemic control than blood and urinary glucose determinations. Diabetic
patients with very high blood concentrations of glucose have from 2 to 3 times more HbA1c than normal individuals.

Please correlate with clinical conditions

~~End of report~~

Dr. SUVARNA KALAMBE (MD PATH)

Consultant Pathologist (Reg. 418)

3 of 11
 PROCESSED AT :
HY PATHO LAB NAGPUR

PT Name : MR RADHESHYAM Age : 42 Year | Sex : Male SAMPLE COLLECTED AT :

Ref By : DR. V.K.SHYAMKUVAR Registered on : 28-06-2025 10:15 AM
Reg No : HL5900686435 / NAGPURLAB/NGP013 Received on : 28-06-2025 12:42 PM
Barcode : HE417231 Reported on : 28-06-2025 01:29 PM
INV : HY MONSOON-1 SAMPLE : EDTA Blood

COMPLETE BLOOD COUNT (CBC)

BIOLOGICAL REFERENCE
TEST DESCRIPTION RESULT UNITS METHOD
RANGE

Hemoglobin 12.9 g/dL 13 - 17 SLS-Hemoglobin

Total Red Blood Cell Count 5.14 10^6/uL 4.52 - 5.5 Electrical Impedance

Hematocrit (HCT) 43.4 % 42 - 50 Calculated

Total Leucocytes Count 7.93 10^3/uL 4 - 10 Electrical Impedance

Neutrophils Percentage 64.6 % 40 - 80 Flow Cytometry

Lymphocyte Percentage 24.1 % 20 - 40 Flow Cytometry

Eosinophils Percentage 5.2 % 1-6 Flow Cytometry

Monocytes Percentage 5.8 % 2 - 10 Flow Cytometry

Basophils Percentage 0.3 % 0.0 - 1.0 Flow Cytometry

Neutrophils-Absolute Count 5.13 10^3/uL 1.8 - 7.8 Calculated

Lymphocytes-Absolute Count 1.92 10^3/uL 0.8 - 4.8 Calculated

Eosinophil-Absolute Count 0.41 10^3/uL 0.0 - 0.9 Calculated

Monocyte- Absolute Count 0.45 10^3/uL 0.50 - 1.00 Calculated

Basophils-Absolute Count 0.02 10^3/uL 0.0 - 0.20 Calculated

Mean Corpuscular Volume (MCV) 84.44 fL 80 - 96 Calculated

Method: RBC HISTOGRAM

Mean Corpuscular Hemoglobin (MCH) 25.1 pg 27 - 32 Calculated

Mean Corpuscular Hemoglobin 29.72 g/dL 31.52 - 35.5 Calculated

Concentration (MCHC)

Red Cell Distribution Width (RDW-CV) 15.6 % 12 - 15 Calculated

Platelet Count 335 10^3/uL 150 - 410 Electrical Impedance

Mean Platelet Volume (MPV) 9.4 fL 6 - 11 Calculated

Platelet haematocrit (PCT) 0.317 % 0.1 - 0.28 Calculated

Platelet Distribution Width (PDW) 14.8 fL 15 - 18 Calculated

~~End of report~~

Dr. SUVARNA KALAMBE (MD PATH)

Consultant Pathologist (Reg. 418)

4 of 11
 PROCESSED AT :
HY PATHO LAB NAGPUR

PT Name : MR RADHESHYAM Age : 42 Year | Sex : Male SAMPLE COLLECTED AT :

Ref By : DR. V.K.SHYAMKUVAR Registered on : 28-06-2025 10:15 AM
Reg No : HL5900686435 / NAGPURLAB/NGP013 Received on : 28-06-2025 12:42 PM
Barcode : EC135375 Reported on : 28-06-2025 01:46 PM
INV : HY MONSOON-1 SAMPLE : Serum

IRON PROFILE

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGE

IRON 103.9 ug/dl 65 - 175

Method: FERROZINE METHOD WITHOUT DEPROTEINIZATION

TOTAL IRON BINDING CAPACITY (TIBC) 436.1 ug/dl 225 - 535

Method: SPECTROPHOTOMETRIC ASSAY

TRANSFERRIN SATURATION % 23.82 % 13 - 45

Method: CALCULATED

Clinical significance :
Iron is an essential trace mineral element which forms an important component of hemoglobin,
metallocompounds and Vitamin A. Deficiency of iron, leads to microcytic hypochromic anemia. The toxic
effects of iron are deposition of iron in various organs of the body and hemochromatosis.

Total Iron Binding capacity (TIBC) is a direct measure of the protein Transferrin which transports iron from
the gut to storage sites in the bone marrow. In iron deficiency anemia, serum iron is reduced and TIBC
increases.

Transferrin Saturation occurs in Idiopathic hemochromatosis and Transfusional hemosiderosis where no

unsaturated iron binding capacity is available for iron mobilization. Similar condition is seen in congenital
deficiency of Transferrin.

Please correlate with clinical conditions

~~End of report~~

Dr. SUVARNA KALAMBE (MD PATH)

Consultant Pathologist (Reg. 418)

5 of 11
 PROCESSED AT :
HY PATHO LAB NAGPUR

PT Name : MR RADHESHYAM Age : 42 Year | Sex : Male SAMPLE COLLECTED AT :

Ref By : DR. V.K.SHYAMKUVAR Registered on : 28-06-2025 10:15 AM
Reg No : HL5900686435 / NAGPURLAB/NGP013 Received on : 28-06-2025 12:42 PM
Barcode : EC135375 Reported on : 28-06-2025 02:45 PM
INV : HY MONSOON-1 SAMPLE : Serum

LIPID PROFILE

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGE

Total Cholesterol 191 mg/dl 0 - 200

Method: CHOD-PAP Borderline high -200-239
High: > 239

Triglycerides 179 mg/dL 0 - 161

Method: GPO Borderline high -161-199
High: 200-499
Very high->499

HDL-Cholesterol 52.74 mg/dl 35.3 - 79.5

Method: Selective Inhbition

LDL- Cholesterol 102.46 mg/dl 60.0 - 130.0

Method: CALCULATED Borderline High: 130-159
High: >160

Cholesterol/HDL ratio 3.62 Ratio 3-5

Method: CALCULATED

VLDL Cholesterol 35.8 mg/dl 6 - 40

Method: CALCULATED

Non HDL Cholesterol 138.26 mg/dl .-.

Method: CALCULATED Normal:<160

LDL /HDL ratio 1.94 Ratio 1.5 - 3.5

Method: CALCULATED

INTERPRETATION
Lipid profiles should be measured as a part of global risk assessment, and the frequency of checkup is determined by age, sex, and risk factors for cardiovascular
disease.
Lipid profile, including triglycerides and total, HDL, and LDL cholesterol, are modifiable factors sensitive to obesity. Recent studies suggest risk of prostate cancer
may increase with obesity-related dyslipidemia, including a low HDL, high LDL and total cholesterol, and high triglycerides. Dyslipidemia may also be related to
increased tumor grade, as evidenced by abnormal HDL level being a strong predictor of developing high-risk disease.

Please correlate with clinical conditions.

~~End of report~~

Dr. SUVARNA KALAMBE (MD PATH)

Consultant Pathologist (Reg. 418)

6 of 11
 PROCESSED AT :
HY PATHO LAB NAGPUR

PT Name : MR RADHESHYAM Age : 42 Year | Sex : Male SAMPLE COLLECTED AT :

Ref By : DR. V.K.SHYAMKUVAR Registered on : 28-06-2025 10:15 AM
Reg No : HL5900686435 / NAGPURLAB/NGP013 Received on : 28-06-2025 12:42 PM
Barcode : EC135375 Reported on : 28-06-2025 02:45 PM
INV : HY MONSOON-1 SAMPLE : Serum

KIDNEY PROFILE

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGE

Urea 35.0 mg/dL 0 - 50

Method: UREASE-GLDH

CREATININE 0.85 mg/dL 0.70 - 1.30

Method: Enzymatic

BUN/Creatinine ratio 19.24 Ratio 8:5 - 23:5

Method: CALCULATED

BUN (Blood Urea Nitrogen) 16.36 mg/dl 7 - 25

Method: CALCULATED

Uric Acid 6.5 mg/dL 3.5 - 7.2

Method: URICASE

Calcium 9.0 mg/dL 8.6 - 10.2

Method: ARSENAZO

SODIUM 141.6 mEq/L 136 - 145

Method: ISE-Electrode Direct

POTASSIUM 4.8 mEq/L 3.6 - 5.1

Method: ISE-Electrode Direct

CHLORIDE 100.6 mEql/L 98 - 107

Method: ISE-Electrode Direct

INTERPRETATION
Kidney function tests are urine or blood tests that evaluate how well your kidneys are working. Most of these tests measure glomerular filtration rate (GFR). GFR
assesses how efficiently your kidneys clear waste from your system.

They help your body filter waste materials and expel them as urine. Your kidneys are also vital for producing:

Hormones that maintain blood pressure.

Red blood cells, which carry oxygen throughout your body.
Vitamin D, which maintains bone and muscle health.

Please correlate with clinical conditions.

~~End of report~~

Dr. SUVARNA KALAMBE (MD PATH)

Consultant Pathologist (Reg. 418)

7 of 11
 PROCESSED AT :
HY PATHO LAB NAGPUR

PT Name : MR RADHESHYAM Age : 42 Year | Sex : Male SAMPLE COLLECTED AT :

Ref By : DR. V.K.SHYAMKUVAR Registered on : 28-06-2025 10:15 AM
Reg No : HL5900686435 / NAGPURLAB/NGP013 Received on : 28-06-2025 12:42 PM
Barcode : EC135375 Reported on : 28-06-2025 02:53 PM
INV : HY MONSOON-1 SAMPLE : Serum

LIVER FUNCTION TESTS

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGE

BILIRUBIN - TOTAL 0.58 mg/dl 0 - 1.20

Method: DIAZO

BILIRUBIN -DIRECT 0.10 mg/dl 0 - 0.40

Method: DIAZO

BILIRUBIN (INDIRECT) 0.48 mg/dl 0 - 0.80

Method: CALCULATED

ASPARTATE AMINOTRANSFERASE (SGOT ) 16 U/L 0 - 35.0

Method: IFCC without P5P

ALANINE TRANSAMINASE (SGPT) 24 U/L 0 - 45.0

Method: IFCC without P5P

ALKALINE PHOSPHATASE 96 U/L 53.0 - 128.0

Method: PMP-AMP

TOTAL-PROTEIN 6.90 g/dL 6.42 - 8.30

Method: Biruet

ALBUMIN - SERUM 4.38 gm/dl 3.5 - 5.2

Method: BCG

GLOBULIN 2.52 gm/dL 2.5 - 3.4

Method: CALCULATED

ALB/GLOBULIN RATIO 1.74 Ratio 0.9 - 2.0

Method: CALCULATED

Gamma GT 41 U/L 0 - 55.0

Method: Glupa-c

INTERPRETATION
Liver function tests (also known as a liver panel) are blood tests that measure different enzymes, proteins, and other substances made by the liver. These tests check
the overall health of your liver. Liver function tests are most often used to:

Help diagnose liver diseases, such as hepatitis

Monitor treatment of liver disease. These tests can show how well the treatment is working.
Check how badly a liver has been damaged or scarred by disease, such as cirrhosis
Monitor side effects of certain medicines

Please correlate with clinical conditions.

~~End of report~~

Dr. SUVARNA KALAMBE (MD PATH)

Consultant Pathologist (Reg. 418)

8 of 11
 PROCESSED AT :
HY PATHO LAB NAGPUR

PT Name : MR RADHESHYAM Age : 42 Year | Sex : Male SAMPLE COLLECTED AT :

Ref By : DR. V.K.SHYAMKUVAR Registered on : 28-06-2025 10:15 AM
Reg No : HL5900686435 / NAGPURLAB/NGP013 Received on : 28-06-2025 12:42 PM
Barcode : EC135375 Reported on : 28-06-2025 02:25 PM
INV : HY MONSOON-1 SAMPLE : Serum

THYROID PROFILE -3 (T3 T4 TSH)

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGE

TOTAL TRIIODOTHYRONINE (T3) 1.15 ng/mL 0.60 - 1.81

Method: CLIA

TOTAL THYROXINE (T4) 7.66 µg/dl 4.5 - 10.9

Method: CLIA

THYROID STIMULATING HORMONE (TSH) 3.11 mIU/ml 0.35 - 5.50

Method: CLIA

Reference Range
Thyroid hormone status during pregnancy:
Pregnancy T3 T4 TSH

1st Trimester 0.70-1.80 6-16.5 0.37 - 3.6

2nd & 3rd Trimester 0.80-2.00 6-18.5 0.38 - 4.04

Reference ranges by Age

0-5 days: 0.7-15.2

6 days-2 months: 0.7-11.0
3-11 months: 0.7-8.4
1-5 years: 0.7-6.0
6-10 years: 0.6-4.8
Interpretation

1. Patients having low T3 and T4 levels but high TSH levels suffer from primary hypothyroidism, cretinism, juvenile myxedema or autoimmune disorders.
2. Patients having high T3 and T4 levels but low TSH levels suffer from Grave's disease, toxic adenoma or sub-acute thyroiditis.
3. Patients having either low or normal T3 and T4 levels but low TSH values suffer from iodine deficiency or secondary hypothyroidism.
4. Patients having high T3 and T4 levels but normal TSH levels may suffer from toxic multinodular goiter. This condition is mostly a symptomatic and may
cause transient hyperthyroidism but no persistent symptoms.
5. Patients with high or normal T3 and T4 levels and low or normal TSH levels suffer either from T3 toxicosis or T4 toxicosis respectively.
6. In patients with non thyroidal illness abnormal test results are not necessarily indicative of thyroidism but may be due to adaptation to thecatabolic state
and may revert to normal when the patient recovers.
7. There are many drugs for eg. Glucocorticoids, Dopamine, Lithium, Iodides, Oral radiographic dyes, etc. which may affect the thyroid function tests.
8. Generally when total T3 and total T4 results are indecisive then Free T3 and Free T4 tests are recommended for further confirmation along with TSH levels.

Please correlate with clinical conditions

~~End of report~~

Dr. SUVARNA KALAMBE (MD PATH)

Consultant Pathologist (Reg. 418)

9 of 11
 PROCESSED AT :
HY PATHO LAB NAGPUR

PT Name : MR RADHESHYAM Age : 42 Year | Sex : Male SAMPLE COLLECTED AT :

Ref By : DR. V.K.SHYAMKUVAR Registered on : 28-06-2025 10:15 AM
Reg No : HL5900686435 / NAGPURLAB/NGP013 Received on : 28-06-2025 12:42 PM
Barcode : EC135375 Reported on : 28-06-2025 02:50 PM
INV : HY MONSOON-1 SAMPLE : Serum

GFR (GLOMERULAR FILTRATION RATE)

BIOLOGICAL REFERENCE
TEST DESCRIPTION RESULT UNITS
RANGE

CREATININE 0.85 mg/dL 0.70 - 1.30

Method: (Enzymatic)

GLOMERULAR FILTRATION RATE 107 mL/min/1.73 m2 .-.

(GFR)
Method: CALCULATED

Reference Range
> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance-
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and moderate kidney injury is poorly inferred
from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement
for assessment of renal function, and report the value when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be
measured easily in clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to interpret information
for the doctor and patient on the degree of renal impairment since it approximately equates to the percentage of kidney function remaining. Application of CKD-EPI
equation together with the other diagnostic tools in renal medicine will further improve the detection and management of patients with CKD.

Please correlate with clinical conditions.

~~End of report~~

Dr. SUVARNA KALAMBE (MD PATH)

Consultant Pathologist (Reg. 418)

10 of 11
 PROCESSED AT :
HY PATHO LAB NAGPUR

PT Name : MR RADHESHYAM Age : 42 Year | Sex : Male SAMPLE COLLECTED AT :

Ref By : DR. V.K.SHYAMKUVAR Registered on : 28-06-2025 10:15 AM
Reg No : HL5900686435 / NAGPURLAB/NGP013 Received on : 28-06-2025 12:42 PM
Barcode : EC135375 Reported on : 28-06-2025 02:52 PM
INV : HY MONSOON-1 SAMPLE : Serum

HS-CRP (HS-C REACTIVE PROTEIN )

TEST DESCRIPTION RESULT UNITS BIOLOGICAL REFERENCE RANGE

HIGH SENSITIVITY C-REACTIVE PROTEIN 2.10 mg/L 0 - 3.0

(HS-CRP)
Method: Immunoturbidimetry

Interpretation:
High sensitivity C-reactive protein, when used in conjunction with other clinical laboratory evaluation of acute coronary syndromes, may be useful as an independent
marker of prognosis for recurrent events, in patients with stable coronary disease or acute coronary syndromes. hsCRP levels should not be substituted for
assessment of traditional cardiovascular risk factors. Patients with persistently unexplained, marked evaluation of hsCRP after repeated testing should be evaluated
for non - cardiovascular etiologies

Clinical significance:

hsCRP measurements may be used as an independent risk marker for the identification of individuals at risk for future cardiovascular disease. Elevated CRP values
may be indicative of prognosis of individuals with acute coronary syndromes, and may be useful in the management of such individuals.

~~End of report~~

Dr. SUVARNA KALAMBE (MD PATH)

Consultant Pathologist (Reg. 418)

11 of 11
Powered by TCPDF (www.tcpdf.org)